Rising COPD Prevalence Fuels Growth In Bronchodilator Market: Strengthening the Growth Trajectory of the Bronchodilators Market

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Bronchodilators Market Through 2025?
Recent years have witnessed robust growth in the bronchodilators market. Its size is projected to increase from $32.93 billion in 2024 to $35.66 billion in 2025, expanding at a compound annual growth rate (CAGR) of 8.3%. Factors like an increasing elderly population, a rise in asthma cases, escalated funding by governmental bodies, an ageing demographic, and heightened levels of air pollution globally are responsible for this growth experienced during the historic period.

What's the Projected Size of the Global Bronchodilators Market by 2029?
In the coming years, the bronchodilators market is anticipated to witness robust growth, escalating to $45.97 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. The surge during this forecasted period can be tied to rising cases of COPD, growing consciousness about treatments for lung diseases bolstered by intensified research and development, increased cases of pulmonary disorders, growing disposable income, and rising smoking rates. Crucial trends projected in the forecast period consist of progressive clinical research and innovative methods, ongoing technological improvements, high occurrence of lung diseases such as COPD and Asthma, introduction of new products, and a growing number of patients with acute respiratory infections.

View the full report here:
https://www.thebusinessresearchcompany.com/report/bronchodilators-global-market-report

Top Growth Drivers in the Bronchodilators Industry: What's Accelerating the Market?
The bronchodilator market is anticipated to grow due to the rising incidence of chronic obstructive pulmonary disease (COPD). This progressive lung disorder is marked by chronic inflammation of the airways and an obstruction or limitation to air flow. COPD treatments often involve bronchodilators, which relax the muscles that surround the airways, thus easing the ability to breathe. As per a report by the Scottish Public Health Observatory, under the direction of Public Health Scotland, a UK-based Population Health Centre, there was a notable increase in COPD cases in March 2023 when the impact of COVID-19 began to diminish. The incidence rate among males rose from 83.2 to 97.6 cases per 100,000, while in females, it escalated from 72.6 to 97.3. As a result, the growing instances of chronic obstructive pulmonary disease (COPD) are boosting the bronchodilator market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13816&type=smp

What Trends Will Shape the Bronchodilators Market Through 2029 and Beyond?
Leading corporations in the bronchodilator market, such as Lupin, are introducing cutting-edge products like fixed-dose triple-drug combinations to enhance patient care. These medications contain three distinct active ingredients in one formulation, each with a set dose. In January 2023, for instance, India-based pharmaceutical company Lupin, unveiled DIFIZMA, a fixed-dose triple-drug bronchodilator containing indacaterol, glycopyrronium, and mometasone specifically for asthma management. Provided as a dry powder inhalation, DIFIZMA is the only such fixed-dose combination that the Drug Controller General of India (DCGI) has sanctioned for the treatment of poorly controlled asthma by enhancing lung function, improving symptom management and minimizing exacerbations.

What Are the Main Segments in the Bronchodilators Market?
The bronchodilators market covered in this report is segmented -

1) By Type: Beta-Adrenergic Bronchodilators, Anticholinergic Bronchodilators, Xanthine Derivatives, Other Types
2) By Route of Administration: Oral, Nasal (Inhalation), Injectable
3) By Indication: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Allergic Reactions, Breathing Problem, Other Indications
4) By End-User: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Beta-Adrenergic Bronchodilators: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs)
2) By Anticholinergic Bronchodilators: Short-Acting Anticholinergics, Long-Acting Anticholinergics
3) By Xanthine Derivatives: Theophylline, Aminophylline
4) By Other Types: Leukotriene Receptor Antagonists, Combination Therapies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13816&type=smp

Which Top Companies are Driving Growth in the Bronchodilators Market?
Major companies operating in the bronchodilators market report are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, Thermo Fisher Scientific, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline plc, Siemens Healthcare GmbH, Merck & Co. Inc., AstraZeneca plc, Teva Pharmaceuticals Industries Ltd., Mylan N.V., Quest Diagnostics Incorporated., Boehringer Ingelheim International GmbH, Aurobindo Pharma Limited, Bio-Rad Laboratories Inc., Cipla Limited, Hikma Pharmaceutical plc, Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Limited, Vectura Group Limited, Foundation Medicine Inc., Sun Pharmaceutical Industries Ltd., Amgen Inc., Kissei Pharmaceutical Co.Ltd., Mitsubishi Tanabe Pharma, Theron Pharmaceuticals, Viatris Inc.

Which Regions Will Dominate the Bronchodilators Market Through 2029?
North America was the largest region in the bronchodilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bronchodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13816

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.